Correlation Engine 2.0
Clear Search sequence regions

  • antigen (5)
  • human (1)
  • layer (2)
  • mice (1)
  • polymer (4)
  • protein polymer (1)
  • protein subunit (6)
  • rna (1)
  • skin thin (1)
  • subunit (1)
  • thin (2)
  • vaccines (1)
  • vaccines subunit (3)
  • vaccines subunit (1)
  • Sizes of these terms reflect their relevance to your search.

    Sustained antigen and adjuvant availability have been shown to improve antiviral immune responses following vaccination. Transcutaneous delivery of vaccines using microneedles has also shown promise and may be particularly relevant for mosquito-borne viruses. We aim to combine these traits to create a three-component Protein Subunit vaccine on Microneedle Arrays (PSMNs) for transcutaneous delivery using layer-by-layer (LbL) assembly. Polymer multilayer thin films were generated to co-deliver a model combination of three chemically distinct vaccine components, a dengue virus Envelope protein Domain III (EDIII) subunit antigen and two adjuvants, a double-stranded RNA (Poly (inosinic:cytidylic acid) (PolyI:C)) and an amphiphilic hexapeptide, Pam3CSK4. Following application of PSMNs to the skin, implanted thin films facilitated sustained and temporal release of individual vaccine components from polymer multilayers. By modulating LbL composition and architecture, component release profiles in the skin could be independently tuned to allow release of adjuvants and antigen from days up to two weeks. Uptake of antigen and adjuvant from implanted vaccine films by antigen-presenting cells was demonstrated using in vivo mouse and ex vivo human skin models. Overall, we believe that such modular vaccine strategies offer design principles for enhancing the immunogenicity of protein subunit vaccines. Copyright © 2020 Elsevier B.V. All rights reserved.


    Divakara S S M Uppu, Michelle E Turvey, Abdul Rahim Mohammed Sharif, Katell Bidet, Yanpu He, Victor Ho, Anagha D Tambe, Julien Lescar, Ern Yu Tan, Katja Fink, Jianzhu Chen, Paula T Hammond. Temporal release of a three-component protein subunit vaccine from polymer multilayers. Journal of controlled release : official journal of the Controlled Release Society. 2020 Jan 10;317:130-141

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 31756392

    View Full Text